EXHIBIT 23.2
Published on
Exhibit
23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in the Registration Statement of
Rexahn Pharmaceuticals, Inc. on Form S-8 (Registration Statement No.
333-129294) of our report dated March 24, 2008 (which report expresses an
unqualified opinion), relating to the financial statements of Rexahn
Pharmaceuticals, Inc. included in this Annual Report on Form 10-K of Rexahn
Pharmaceuticals, Inc. for the year ended December 31, 2008.
/s/ Lazar, Levine &
Felix, LLP
New York,
New York
March 13,
2009